Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial
Kim, Hyun-Sook, Choi, Won-Ho, Kim, Bo Young, Kim, Sung Soo, Lee, Sang-Il, Kim, Sang-Hyon, Choi, Sung Jae, Kim, Geun-Tae, Hur, Jin-Wuk, Lee, Myeung-Su, Kim, Yun Sung, Hong, Seung-JaeТом:
48
Журнал:
Journal of International Medical Research
DOI:
10.1177/0300060520931323
Date:
June, 2020
Файл:
PDF, 729 KB
2020
File converter
Більше результатів пошуку
More benefits 
